Global Biological Sample Cryopreservation Market Analysis and Forecast 2026-2032

Biological Sample Cryopreservation encompasses the controlled freezing, vitrification, and cryogenic storage technologies used to preserve living cells, tissues, reproductive materials, microorganisms, and temperature sensitive biological specimens for subsequent recovery, analysis, or biological use. The underlying preservation mechanism involves reducing molecular mobility, enzymatic activity, and biochemical degradation at ultralow temperatures while limiting structural and functional damage associated with ice crystallization, osmotic imbalance, solute concentration, and membrane disruption. Conventional slow freezing applies controlled cooling rates to promote extracellular ice formation and cellular dehydration while reducing intracellular ice formation. Vitrification uses higher cryoprotectant concentrations and rapid temperature transitions to produce an amorphous solid state with minimal ice crystallization. Cryoprotective formulations incorporate permeating agents such as dimethyl sulfoxide, glycerol, and ethylene glycol, together with nonpermeating sugars, buffering systems, and other formulation components selected according to sample characteristics and freezing methods. Preservation performance depends on the interaction between cooling rate, cryoprotectant composition, sample volume, thermal history, storage temperature, and subsequent warming conditions.
Commercial cryopreservation technologies include programmable controlled rate freezers, mechanical ultralow temperature and cryogenic freezers, liquid nitrogen storage systems, automated cryogenic sample repositories, and specialized cryopreservation media. Equipment configurations incorporate cascade refrigeration circuits, liquid nitrogen cooling and distribution assemblies, vacuum insulated stainless steel vessels, thermal control systems, and automated sample handling mechanisms. Mechanical freezers operating near minus 80°C accommodate biological materials with compatible storage requirements, while systems operating near minus 150°C and liquid nitrogen environments approaching minus 196°C are used for extended preservation of viable cellular specimens. Cryogenic storage may employ liquid phase or nitrogen vapor phase configurations, with storage architecture determined by sample characteristics, thermal stability requirements, and contamination considerations. Commercial applications encompass biological sample repositories, biomedical research, biopharmaceutical cell banking and manufacturing, cell and gene therapy, assisted reproduction, clinical specimen preservation, and animal breeding. The product market covers dedicated freezing and cryogenic storage equipment and formulated cryopreservation media used directly in biological preservation. Independent storage and logistics services, general laboratory refrigeration, standalone sample packaging consumables, and unrelated laboratory equipment fall outside the product revenue boundary.
Product & engineering
Understand the product.
Biological Sample Cryopreservation encompasses the controlled freezing, vitrification, and cryogenic storage technologies used to preserve living cells, tissues, reproductive materials, microorganisms, and temperature sensitive biological specimens for subsequent recovery, analysis, or biological use. The underlying preservation mechanism involves reducing molecular mobility, enzymatic activity, and biochemical degradation at ultralow temperatures while limiting structural and functional damage associated with ice crystallization, osmotic imbalance, solute concentration, and membrane disruption. Conventional slow freezing applies controlled cooling rates to promote extracellular ice formation and cellular dehydration while reducing intracellular ice formation. Vitrification uses higher cryoprotectant concentrations and rapid temperature transitions to produce an amorphous solid state with minimal ice crystallization. Cryoprotective formulations incorporate permeating agents such as dimethyl sulfoxide, glycerol, and ethylene glycol, together with nonpermeating sugars, buffering systems, and other formulation components selected according to sample characteristics and freezing methods. Preservation performance depends on the interaction between cooling rate, cryoprotectant composition, sample volume, thermal history, storage temperature, and subsequent warming conditions.
Commercial cryopreservation technologies include programmable controlled rate freezers, mechanical ultralow temperature and cryogenic freezers, liquid nitrogen storage systems, automated cryogenic sample repositories, and specialized cryopreservation media. Equipment configurations incorporate cascade refrigeration circuits, liquid nitrogen cooling and distribution assemblies, vacuum insulated stainless steel vessels, thermal control systems, and automated sample handling mechanisms. Mechanical freezers operating near minus 80°C accommodate biological materials with compatible storage requirements, while systems operating near minus 150°C and liquid nitrogen environments approaching minus 196°C are used for extended preservation of viable cellular specimens. Cryogenic storage may employ liquid phase or nitrogen vapor phase configurations, with storage architecture determined by sample characteristics, thermal stability requirements, and contamination considerations. Commercial applications encompass biological sample repositories, biomedical research, biopharmaceutical cell banking and manufacturing, cell and gene therapy, assisted reproduction, clinical specimen preservation, and animal breeding. The product market covers dedicated freezing and cryogenic storage equipment and formulated cryopreservation media used directly in biological preservation. Independent storage and logistics services, general laboratory refrigeration, standalone sample packaging consumables, and unrelated laboratory equipment fall outside the product revenue boundary.
Selected research
Market Analysis & Forecast
Global Biological Sample Cryopreservation Market Analysis and Forecast 2026-2032
MARKET AT A GLANCE
Scale & outlook
- 2024
- ≈ 860USD million
- 2032
- 3,057.45USD million
Select a bar to inspect its value.
Source: APO Research, Inc.
Market perspective
According to APO Research, Inc, the global Biological Sample Cryopreservation market was valued at approximately USD 1,812.4 million in 2025 and is projected to reach USD 1,933.15 million in 2026 and USD 3,057.45 million by 2032, representing a compound annual growth rate (CAGR) of 7.94% from 2026 to 2032. Market revenue comprises dedicated controlled rate freezing equipment, ultralow temperature and cryogenic storage systems, automated biological sample repositories, and commercial cryopreservation media. Growth is driven by expanding biological specimen inventories, increased production of cell based therapeutics, and replacement of aging laboratory storage equipment. Equipment revenue depends on new installations, replacement cycles, and average selling prices, while cryopreservation media consumption follows the number of biological samples and cell manufacturing batches processed. Automated liquid nitrogen storage systems increase equipment expenditure per installation where sample capacity, retrieval frequency, and handling requirements justify additional capital investment.
Ultralow temperature freezers represent an established component of biological sample storage infrastructure. PHC Group estimated the global ultralow temperature freezer market at approximately USD 860 million in 2024 and identified emerging replacement demand for energy efficient equipment among pharmaceutical manufacturers and contract development and manufacturing organizations. Research institutions and biobanks face similar requirements as existing freezer fleets age and electricity consumption becomes a larger component of operating expenditure. In China, Haier Biomedical manufactures ultralow temperature storage equipment in Qingdao and intelligent liquid nitrogen storage systems in Chengdu, providing domestic manufacturing capacity across conventional and cryogenic storage technologies. Equipment demand in China and other Asian markets is influenced by biological sample repository development, pharmaceutical manufacturing investment, and the adoption of automated storage systems. North America, Europe, and Japan additionally generate replacement demand from established laboratory and biopharmaceutical infrastructure. Conventional freezer pricing remains subject to manufacturer competition, while automated cryogenic installations carry higher equipment values associated with insulated storage vessels, robotic handling, monitoring, and temperature management systems.
Cryogenic storage equipment and specialized preservation media are also influenced by the commercialization of advanced therapies and reproductive technologies. Cryoport reported USD 79.68 million in Life Sciences Products revenue in 2025, an increase of 6.6%, with stronger product demand in Europe, the Middle East, Africa, and Asia Pacific, alongside animal health applications in the Americas. Its product revenue includes cryogenic storage and transport equipment, reflecting demand from biological repositories, reproductive material preservation, and commercial cell therapy supply chains. BioLife Solutions reported USD 96.2 million in 2025 revenue, with biopreservation media accounting for approximately 87% of its business, including cryogenic freezing and hypothermic preservation formulations. Repligen completed its acquisition of BioLife Solutions in October 2026, adding the CryoStor cryopreservation media family to its bioprocessing business. As cell therapies advance from clinical development into commercial manufacturing, repeated production batches and frozen cellular inventories increase consumption of qualified freezing formulations. Cryoprotectant composition, post thaw cell recovery, and manufacturing process compatibility influence product selection and limit rapid substitution of established formulations. The market outlook consequently reflects continued equipment installations and replacements, a rising contribution from automated cryogenic storage, and recurring preservation media purchases tied to biological manufacturing activity.
Full market overview
Report Includes
This report presents an overview of global market for Biological Sample Cryopreservation, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Biological Sample Cryopreservation, also provides the revenue of main regions and countries. Of the upcoming market potential for Biological Sample Cryopreservation, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Biological Sample Cryopreservation revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Biological Sample Cryopreservation market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Biological Sample Cryopreservation revenue, projected growth trends, production technology, application and end-user industry.
Biological Sample Cryopreservation Segment by Company
- Thermo Fisher Scientific
- Haier Biomedical
- PHCbi
- Repligen
- Cryoport
- Azenta Life Sciences
- Cytiva
- Sartorius
- FUJIFILM Biosciences
- Lonza
- Corning
- Eppendorf
- Greiner
- SARSTEDT
- Terumo
- CooperSurgical
- Vitrolife
- Nexpring Health
- Macopharma
- Miltenyi Biotec
- STEMCELL Technologies
- Kitazato
- Zhongke Meiling Cryogenics
- AUCMA
- BIOBASE
- Genepoint Technologies
- Origincell Biological Cryo Equipment
- Basecare Medical
- Hamilton Company
- LiCONiC
- ASKION
- SPT Labtech
- B Medical Systems
- Custom Biogenic Systems
- IC Biomedical
- Cryo Bio System
- Stirling Ultracold
- Helmer Scientific
- Micronic
- OriGen Biomedical
- BINDER
- Liebherr
- Esco Lifesciences
- Cryopal
- Cryotherm
- Cryo Diffusion
- Statebourne Cryogenics
- Celltrio
- ThermoGenesis
- Jiangsu SERLNG
- SYLAB
- Consarctic
- PromoCell
- FertiPro
- CryoLogic
- Cryofab
Biological Sample Cryopreservation Segment by Type
- Cryopreservation Equipment
- Cryopreservation Media & Reagents
- Cryopreservation Containers & Accessories
- Cryopreservation Services
Biological Sample Cryopreservation Segment by Application
- Biobanking
- Biomedical Research
- Biopharmaceutical Manufacturing
- Cell & Gene Therapy
- Assisted Reproduction
- Clinical Diagnostics
- Animal Breeding
Biological Sample Cryopreservation Segment by Region
- North America
- United States
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Spain
- Netherlands
- Switzerland
- Sweden
- Poland
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- Taiwan
- Southeast Asia
- South America
- Brazil
- Argentina
- Chile
- Colombia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Türkiye
- GCC Countries
Study Objectives
- To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
- To present the key players, revenue, market share, and Recent Developments.
- To split the breakdown data by regions, type, manufacturers, and Application.
- To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
- To identify significant trends, drivers, influence factors in global and regions.
- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
- This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biological Sample Cryopreservation market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
- This report will help stakeholders to understand the global industry status and trends of Biological Sample Cryopreservation and provides them with information on key market drivers, restraints, challenges, and opportunities.
- This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
- This report stays updated with novel technology integration, features, and the latest developments in the market.
- This report helps stakeholders to gain insights into which regions to target globally.
- This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biological Sample Cryopreservation.
- This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
- Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
- Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
- Chapter 3: Revenue of Biological Sample Cryopreservation in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
- Chapter 4: Detailed analysis of Biological Sample Cryopreservation company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
- Chapter 5: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
- Chapter 6: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
- Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Biological Sample Cryopreservation revenue, gross margin, and recent development, etc.
- Chapter 8: North America by Type, by Application and by country, revenue for each segment.
- Chapter 9: Europe by Type, by Application and by country, revenue for each segment.
- Chapter 10: China type, by Application, revenue for each segment.
- Chapter 11: Asia (excluding China) type, by Application and by region, revenue for each segment.
- Chapter 12: South America, Middle East and Africa by Type, by Application and by country, revenue for each segment.
- Chapter 13: The main concluding insights of the report.
More report detail
Tables and figures
List of Tables
- Table 1. Global Biological Sample Cryopreservation Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032
- Table 2. Cryopreservation Equipment Major Player
- Table 3. Cryopreservation Media & Reagents Major Player
- Table 4. Cryopreservation Containers & Accessories Major Player
- Table 5. Cryopreservation Services Major Player
- Table 6. Global Biological Sample Cryopreservation Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032
- Table 7. Biobanking Major Player
- Table 8. Biomedical Research Major Player
- Table 9. Biopharmaceutical Manufacturing Major Player
- Table 10. Cell & Gene Therapy Major Player
- Table 11. Assisted Reproduction Major Player
- Table 12. Clinical Diagnostics Major Player
- Table 13. Animal Breeding Major Player
- Table 14. Biological Sample Cryopreservation Industry Trends
- Table 15. Biological Sample Cryopreservation Industry Drivers
- Table 16. Biological Sample Cryopreservation Industry Opportunities and Challenges
- Table 17. Biological Sample Cryopreservation Industry Restraints
- Table 18. Global Biological Sample Cryopreservation Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032
- Table 19. Global Biological Sample Cryopreservation Market Size by Region (2021-2026) & (US$ Million)
- Table 20. Global Biological Sample Cryopreservation Market Share by Region (2021-2026)
- Table 21. Global Biological Sample Cryopreservation Market Size by Region (2027-2032) & (US$ Million)
- Table 22. Global Biological Sample Cryopreservation Market Share by Region (2027-2032)
- Table 23. Global Biological Sample Cryopreservation Revenue by Players (US$ Million) & (2021-2026)
- Table 24. Global Biological Sample Cryopreservation Revenue Market Share by Players (2021-2026)
- Table 25. Global Biological Sample Cryopreservation Key Players Ranking, 2024 VS 2025 VS 2026
- Table 26. Global Biological Sample Cryopreservation Key Players Headquarters & Area Served
- Table 27. Global Biological Sample Cryopreservation Players, Product Type & Application
- Table 28. Global Biological Sample Cryopreservation Players Establishment Date
- Table 29. Global Players Market Concentration Ratio (CR5 and HHI)
- Table 30. Global Biological Sample Cryopreservation by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025)
- Table 31. Global Biological Sample Cryopreservation Revenue by Type 2021 VS 2025 VS 2032 (US$ Million)
- Table 32. Global Biological Sample Cryopreservation Revenue by Type (2021-2026) & (US$ Million)
- Table 33. Global Biological Sample Cryopreservation Revenue by Type (2027-2032) & (US$ Million)
- Table 34. Global Biological Sample Cryopreservation Revenue Market Share by Type (2021-2026)
- Table 35. Global Biological Sample Cryopreservation Revenue Market Share by Type (2027-2032)
- Table 36. Global Biological Sample Cryopreservation Revenue by Application 2021 VS 2025 VS 2032 (US$ Million)
- Table 37. Global Biological Sample Cryopreservation Revenue by Application (2021-2026) & (US$ Million)
- Table 38. Global Biological Sample Cryopreservation Revenue by Application (2027-2032) & (US$ Million)
- Table 39. Global Biological Sample Cryopreservation Revenue Market Share by Application (2021-2026)
- Table 40. Global Biological Sample Cryopreservation Revenue Market Share by Application (2027-2032)
- Table 41. Thermo Fisher Scientific Company Information
- Table 42. Thermo Fisher Scientific Business Overview
- Table 43. Thermo Fisher Scientific Biological Sample Cryopreservation Revenue and Gross Margin (US$ Million) & (2021-2026)
- Table 44. Thermo Fisher Scientific Biological Sample Cryopreservation Product Portfolio
- Table 45. Thermo Fisher Scientific Recent Development
- Table 46. Haier Biomedical Company Information
- Table 47. Haier Biomedical Business Overview
- Table 48. Haier Biomedical Biological Sample Cryopreservation Revenue and Gross Margin (US$ Million) & (2021-2026)
- Table 49. Haier Biomedical Biological Sample Cryopreservation Product Portfolio
- Table 50. Haier Biomedical Recent Development
- Table 51. PHCbi Company Information
- Table 52. PHCbi Business Overview
- Table 53. PHCbi Biological Sample Cryopreservation Revenue and Gross Margin (US$ Million) & (2021-2026)
- Table 54. PHCbi Biological Sample Cryopreservation Product Portfolio
- Table 55. PHCbi Recent Development
- Table 56. Repligen Company Information
- Table 57. Repligen Business Overview
- Table 58. Repligen Biological Sample Cryopreservation Revenue and Gross Margin (US$ Million) & (2021-2026)
- Table 59. Repligen Biological Sample Cryopreservation Product Portfolio
- Table 60. Repligen Recent Development
- Table 61. Cryoport Company Information
- Table 62. Cryoport Business Overview
- Table 63. Cryoport Biological Sample Cryopreservation Revenue and Gross Margin (US$ Million) & (2021-2026)
- Table 64. Cryoport Biological Sample Cryopreservation Product Portfolio
- Table 65. Cryoport Recent Development
- Table 66. Azenta Life Sciences Company Information
- Table 67. Azenta Life Sciences Business Overview
- Table 68. Azenta Life Sciences Biological Sample Cryopreservation Revenue and Gross Margin (US$ Million) & (2021-2026)
- Table 69. Azenta Life Sciences Biological Sample Cryopreservation Product Portfolio
- Table 70. Azenta Life Sciences Recent Development
- Table 71. Cytiva Company Information
- Table 72. Cytiva Business Overview
- Table 73. Cytiva Biological Sample Cryopreservation Revenue and Gross Margin (US$ Million) & (2021-2026)
- Table 74. Cytiva Biological Sample Cryopreservation Product Portfolio
- Table 75. Cytiva Recent Development
- Table 76. Sartorius Company Information
- Table 77. Sartorius Business Overview
- Table 78. Sartorius Biological Sample Cryopreservation Revenue and Gross Margin (US$ Million) & (2021-2026)
- Table 79. Sartorius Biological Sample Cryopreservation Product Portfolio
- Table 80. Sartorius Recent Development
- Table 81. FUJIFILM Biosciences Company Information
- Table 82. FUJIFILM Biosciences Business Overview
- Table 83. FUJIFILM Biosciences Biological Sample Cryopreservation Revenue and Gross Margin (US$ Million) & (2021-2026)
- Table 84. FUJIFILM Biosciences Biological Sample Cryopreservation Product Portfolio
- Table 85. FUJIFILM Biosciences Recent Development
- Table 86. Lonza Company Information
- Table 87. Lonza Business Overview
- Table 88. Lonza Biological Sample Cryopreservation Revenue and Gross Margin (US$ Million) & (2021-2026)
- Table 89. Lonza Biological Sample Cryopreservation Product Portfolio
- Table 90. Lonza Recent Development
- Table 91. Corning Company Information
- Table 92. Corning Business Overview
- Table 93. Corning Biological Sample Cryopreservation Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
- Table 94. Corning Biological Sample Cryopreservation Product Portfolio
- Table 95. Corning Recent Development
- Table 96. Eppendorf Company Information
- Table 97. Eppendorf Business Overview
- Table 98. Eppendorf Biological Sample Cryopreservation Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
- Table 99. Eppendorf Biological Sample Cryopreservation Product Portfolio
- Table 100. Eppendorf Recent Development
- Table 101. Greiner Company Information
- Table 102. Greiner Business Overview
- Table 103. Greiner Biological Sample Cryopreservation Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
- Table 104. Greiner Biological Sample Cryopreservation Product Portfolio
- Table 105. Greiner Recent Development
- Table 106. SARSTEDT Company Information
- Table 107. SARSTEDT Business Overview
- Table 108. SARSTEDT Biological Sample Cryopreservation Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
- Table 109. SARSTEDT Biological Sample Cryopreservation Product Portfolio
- Table 110. SARSTEDT Recent Development
- Table 111. Terumo Company Information
- Table 112. Terumo Business Overview
- Table 113. Terumo Biological Sample Cryopreservation Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
- Table 114. Terumo Biological Sample Cryopreservation Product Portfolio
- Table 115. Terumo Recent Development
- Table 116. CooperSurgical Company Information
- Table 117. CooperSurgical Business Overview
- Table 118. CooperSurgical Biological Sample Cryopreservation Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
- Table 119. CooperSurgical Biological Sample Cryopreservation Product Portfolio
- Table 120. CooperSurgical Recent Development
- Table 121. Vitrolife Company Information
- Table 122. Vitrolife Business Overview
- Table 123. Vitrolife Biological Sample Cryopreservation Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
- Table 124. Vitrolife Biological Sample Cryopreservation Product Portfolio
- Table 125. Vitrolife Recent Development
- Table 126. Nexpring Health Company Information
- Table 127. Nexpring Health Business Overview
- Table 128. Nexpring Health Biological Sample Cryopreservation Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
- Table 129. Nexpring Health Biological Sample Cryopreservation Product Portfolio
- Table 130. Nexpring Health Recent Development
- Table 131. Macopharma Company Information
- Table 132. Macopharma Business Overview
- Table 133. Macopharma Biological Sample Cryopreservation Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
- Table 134. Macopharma Biological Sample Cryopreservation Product Portfolio
- Table 135. Macopharma Recent Development
- Table 136. Miltenyi Biotec Company Information
- Table 137. Miltenyi Biotec Business Overview
- Table 138. Miltenyi Biotec Biological Sample Cryopreservation Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
- Table 139. Miltenyi Biotec Biological Sample Cryopreservation Product Portfolio
- Table 140. Miltenyi Biotec Recent Development
- Table 141. STEMCELL Technologies Company Information
- Table 142. STEMCELL Technologies Business Overview
- Table 143. STEMCELL Technologies Biological Sample Cryopreservation Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
- Table 144. STEMCELL Technologies Biological Sample Cryopreservation Product Portfolio
- Table 145. STEMCELL Technologies Recent Development
- Table 146. Kitazato Company Information
- Table 147. Kitazato Business Overview
- Table 148. Kitazato Biological Sample Cryopreservation Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
- Table 149. Kitazato Biological Sample Cryopreservation Product Portfolio
- Table 150. Kitazato Recent Development
- Table 151. Zhongke Meiling Cryogenics Company Information
- Table 152. Zhongke Meiling Cryogenics Business Overview
- Table 153. Zhongke Meiling Cryogenics Biological Sample Cryopreservation Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
- Table 154. Zhongke Meiling Cryogenics Biological Sample Cryopreservation Product Portfolio
- Table 155. Zhongke Meiling Cryogenics Recent Development
- Table 156. AUCMA Company Information
- Table 157. AUCMA Business Overview
- Table 158. AUCMA Biological Sample Cryopreservation Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
- Table 159. AUCMA Biological Sample Cryopreservation Product Portfolio
- Table 160. AUCMA Recent Development
- Table 161. BIOBASE Company Information
- Table 162. BIOBASE Business Overview
- Table 163. BIOBASE Biological Sample Cryopreservation Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
- Table 164. BIOBASE Biological Sample Cryopreservation Product Portfolio
- Table 165. BIOBASE Recent Development
- Table 166. Genepoint Technologies Company Information
- Table 167. Genepoint Technologies Business Overview
- Table 168. Genepoint Technologies Biological Sample Cryopreservation Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
- Table 169. Genepoint Technologies Biological Sample Cryopreservation Product Portfolio
- Table 170. Genepoint Technologies Recent Development
- Table 171. Origincell Biological Cryo Equipment Company Information
- Table 172. Origincell Biological Cryo Equipment Business Overview
- Table 173. Origincell Biological Cryo Equipment Biological Sample Cryopreservation Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
- Table 174. Origincell Biological Cryo Equipment Biological Sample Cryopreservation Product Portfolio
- Table 175. Origincell Biological Cryo Equipment Recent Development
- Table 176. Basecare Medical Company Information
- Table 177. Basecare Medical Business Overview
- Table 178. Basecare Medical Biological Sample Cryopreservation Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
- Table 179. Basecare Medical Biological Sample Cryopreservation Product Portfolio
- Table 180. Basecare Medical Recent Development
- Table 181. Hamilton Company Company Information
- Table 182. Hamilton Company Business Overview
- Table 183. Hamilton Company Biological Sample Cryopreservation Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
- Table 184. Hamilton Company Biological Sample Cryopreservation Product Portfolio
- Table 185. Hamilton Company Recent Development
- Table 186. LiCONiC Company Information
- Table 187. LiCONiC Business Overview
- Table 188. LiCONiC Biological Sample Cryopreservation Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
- Table 189. LiCONiC Biological Sample Cryopreservation Product Portfolio
- Table 190. LiCONiC Recent Development
- Table 191. ASKION Company Information
- Table 192. ASKION Business Overview
- Table 193. ASKION Biological Sample Cryopreservation Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
- Table 194. ASKION Biological Sample Cryopreservation Product Portfolio
- Table 195. ASKION Recent Development
- Table 196. SPT Labtech Company Information
- Table 197. SPT Labtech Business Overview
- Table 198. SPT Labtech Biological Sample Cryopreservation Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
- Table 199. SPT Labtech Biological Sample Cryopreservation Product Portfolio
- Table 200. SPT Labtech Recent Development
- Table 201. B Medical Systems Company Information
- Table 202. B Medical Systems Business Overview
- Table 203. B Medical Systems Biological Sample Cryopreservation Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
- Table 204. B Medical Systems Biological Sample Cryopreservation Product Portfolio
- Table 205. B Medical Systems Recent Development
- Table 206. Custom Biogenic Systems Company Information
- Table 207. Custom Biogenic Systems Business Overview
- Table 208. Custom Biogenic Systems Biological Sample Cryopreservation Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
- Table 209. Custom Biogenic Systems Biological Sample Cryopreservation Product Portfolio
- Table 210. Custom Biogenic Systems Recent Development
- Table 211. IC Biomedical Company Information
- Table 212. IC Biomedical Business Overview
- Table 213. IC Biomedical Biological Sample Cryopreservation Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
- Table 214. IC Biomedical Biological Sample Cryopreservation Product Portfolio
- Table 215. IC Biomedical Recent Development
- Table 216. Cryo Bio System Company Information
- Table 217. Cryo Bio System Business Overview
- Table 218. Cryo Bio System Biological Sample Cryopreservation Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
- Table 219. Cryo Bio System Biological Sample Cryopreservation Product Portfolio
- Table 220. Cryo Bio System Recent Development
- Table 221. Stirling Ultracold Company Information
- Table 222. Stirling Ultracold Business Overview
- Table 223. Stirling Ultracold Biological Sample Cryopreservation Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
- Table 224. Stirling Ultracold Biological Sample Cryopreservation Product Portfolio
- Table 225. Stirling Ultracold Recent Development
- Table 226. Helmer Scientific Company Information
- Table 227. Helmer Scientific Business Overview
- Table 228. Helmer Scientific Biological Sample Cryopreservation Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
- Table 229. Helmer Scientific Biological Sample Cryopreservation Product Portfolio
- Table 230. Helmer Scientific Recent Development
- Table 231. Micronic Company Information
- Table 232. Micronic Business Overview
- Table 233. Micronic Biological Sample Cryopreservation Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
- Table 234. Micronic Biological Sample Cryopreservation Product Portfolio
- Table 235. Micronic Recent Development
- Table 236. OriGen Biomedical Company Information
- Table 237. OriGen Biomedical Business Overview
- Table 238. OriGen Biomedical Biological Sample Cryopreservation Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
- Table 239. OriGen Biomedical Biological Sample Cryopreservation Product Portfolio
- Table 240. OriGen Biomedical Recent Development
- Table 241. BINDER Company Information
- Table 242. BINDER Business Overview
- Table 243. BINDER Biological Sample Cryopreservation Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
- Table 244. BINDER Biological Sample Cryopreservation Product Portfolio
- Table 245. BINDER Recent Development
- Table 246. Liebherr Company Information
- Table 247. Liebherr Business Overview
- Table 248. Liebherr Biological Sample Cryopreservation Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
- Table 249. Liebherr Biological Sample Cryopreservation Product Portfolio
- Table 250. Liebherr Recent Development
- Table 251. Esco Lifesciences Company Information
- Table 252. Esco Lifesciences Business Overview
- Table 253. Esco Lifesciences Biological Sample Cryopreservation Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
- Table 254. Esco Lifesciences Biological Sample Cryopreservation Product Portfolio
- Table 255. Esco Lifesciences Recent Development
- Table 256. Cryopal Company Information
- Table 257. Cryopal Business Overview
- Table 258. Cryopal Biological Sample Cryopreservation Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
- Table 259. Cryopal Biological Sample Cryopreservation Product Portfolio
- Table 260. Cryopal Recent Development
- Table 261. Cryotherm Company Information
- Table 262. Cryotherm Business Overview
- Table 263. Cryotherm Biological Sample Cryopreservation Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
- Table 264. Cryotherm Biological Sample Cryopreservation Product Portfolio
- Table 265. Cryotherm Recent Development
- Table 266. Cryo Diffusion Company Information
- Table 267. Cryo Diffusion Business Overview
- Table 268. Cryo Diffusion Biological Sample Cryopreservation Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
- Table 269. Cryo Diffusion Biological Sample Cryopreservation Product Portfolio
- Table 270. Cryo Diffusion Recent Development
- Table 271. Statebourne Cryogenics Company Information
- Table 272. Statebourne Cryogenics Business Overview
- Table 273. Statebourne Cryogenics Biological Sample Cryopreservation Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
- Table 274. Statebourne Cryogenics Biological Sample Cryopreservation Product Portfolio
- Table 275. Statebourne Cryogenics Recent Development
- Table 276. Celltrio Company Information
- Table 277. Celltrio Business Overview
- Table 278. Celltrio Biological Sample Cryopreservation Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
- Table 279. Celltrio Biological Sample Cryopreservation Product Portfolio
- Table 280. Celltrio Recent Development
- Table 281. ThermoGenesis Company Information
- Table 282. ThermoGenesis Business Overview
- Table 283. ThermoGenesis Biological Sample Cryopreservation Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
- Table 284. ThermoGenesis Biological Sample Cryopreservation Product Portfolio
- Table 285. ThermoGenesis Recent Development
- Table 286. Jiangsu SERLNG Company Information
- Table 287. Jiangsu SERLNG Business Overview
- Table 288. Jiangsu SERLNG Biological Sample Cryopreservation Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
- Table 289. Jiangsu SERLNG Biological Sample Cryopreservation Product Portfolio
- Table 290. Jiangsu SERLNG Recent Development
- Table 291. SYLAB Company Information
- Table 292. SYLAB Business Overview
- Table 293. SYLAB Biological Sample Cryopreservation Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
- Table 294. SYLAB Biological Sample Cryopreservation Product Portfolio
- Table 295. SYLAB Recent Development
- Table 296. Consarctic Company Information
- Table 297. Consarctic Business Overview
- Table 298. Consarctic Biological Sample Cryopreservation Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
- Table 299. Consarctic Biological Sample Cryopreservation Product Portfolio
- Table 300. Consarctic Recent Development
- Table 301. PromoCell Company Information
- Table 302. PromoCell Business Overview
- Table 303. PromoCell Biological Sample Cryopreservation Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
- Table 304. PromoCell Biological Sample Cryopreservation Product Portfolio
- Table 305. PromoCell Recent Development
- Table 306. FertiPro Company Information
- Table 307. FertiPro Business Overview
- Table 308. FertiPro Biological Sample Cryopreservation Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
- Table 309. FertiPro Biological Sample Cryopreservation Product Portfolio
- Table 310. FertiPro Recent Development
- Table 311. CryoLogic Company Information
- Table 312. CryoLogic Business Overview
- Table 313. CryoLogic Biological Sample Cryopreservation Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
- Table 314. CryoLogic Biological Sample Cryopreservation Product Portfolio
- Table 315. CryoLogic Recent Development
- Table 316. Cryofab Company Information
- Table 317. Cryofab Business Overview
- Table 318. Cryofab Biological Sample Cryopreservation Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
- Table 319. Cryofab Biological Sample Cryopreservation Product Portfolio
- Table 320. Cryofab Recent Development
- Table 321. North America Biological Sample Cryopreservation Revenue by Type (2021-2026) & (US$ Million)
- Table 322. North America Biological Sample Cryopreservation Revenue by Type (2027-2032) & (US$ Million)
- Table 323. North America Biological Sample Cryopreservation Revenue by Application (2021-2026) & (US$ Million)
- Table 324. North America Biological Sample Cryopreservation Revenue by Application (2027-2032) & (US$ Million)
- Table 325. North America Biological Sample Cryopreservation Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million)
- Table 326. North America Biological Sample Cryopreservation Revenue by Country (2021-2026) & (US$ Million)
- Table 327. North America Biological Sample Cryopreservation Revenue by Country (US$ Million) & (2027-2032)
- Table 328. Europe Biological Sample Cryopreservation Revenue by Type (2021-2026) & (US$ Million)
- Table 329. Europe Biological Sample Cryopreservation Revenue by Type (2027-2032) & (US$ Million)
- Table 330. Europe Biological Sample Cryopreservation Revenue by Application (2021-2026) & (US$ Million)
- Table 331. Europe Biological Sample Cryopreservation Revenue by Application (2027-2032) & (US$ Million)
- Table 332. Europe Biological Sample Cryopreservation Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million)
- Table 333. Europe Biological Sample Cryopreservation Revenue by Country (2021-2026) & (US$ Million)
- Table 334. Europe Biological Sample Cryopreservation Revenue by Country (US$ Million) & (2027-2032)
- Table 335. China Biological Sample Cryopreservation Revenue by Type (2021-2026) & (US$ Million)
- Table 336. China Biological Sample Cryopreservation Revenue by Type (2027-2032) & (US$ Million)
- Table 337. China Biological Sample Cryopreservation Revenue by Application (2021-2026) & (US$ Million)
- Table 338. China Biological Sample Cryopreservation Revenue by Application (2027-2032) & (US$ Million)
- Table 339. Asia Biological Sample Cryopreservation Revenue by Type (2021-2026) & (US$ Million)
- Table 340. Asia Biological Sample Cryopreservation Revenue by Type (2027-2032) & (US$ Million)
- Table 341. Asia Biological Sample Cryopreservation Revenue by Application (2021-2026) & (US$ Million)
- Table 342. Asia Biological Sample Cryopreservation Revenue by Application (2027-2032) & (US$ Million)
- Table 343. Asia Biological Sample Cryopreservation Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million)
- Table 344. Asia Biological Sample Cryopreservation Revenue by Region (US$ Million) & (2021-2026)
- Table 345. Asia Biological Sample Cryopreservation Revenue by Region (US$ Million) & (2027-2032)
- Table 346. SAMEA Biological Sample Cryopreservation Revenue by Type (2021-2026) & (US$ Million)
- Table 347. SAMEA Biological Sample Cryopreservation Revenue by Type (2027-2032) & (US$ Million)
- Table 348. SAMEA Biological Sample Cryopreservation Revenue by Application (2021-2026) & (US$ Million)
- Table 349. SAMEA Biological Sample Cryopreservation Revenue by Application (2027-2032) & (US$ Million)
- Table 350. SAMEA Biological Sample Cryopreservation Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million)
- Table 351. SAMEA Biological Sample Cryopreservation Revenue by Country (2021-2026) & (US$ Million)
- Table 352. SAMEA Biological Sample Cryopreservation Revenue by Country (US$ Million) & (2027-2032)
- Table 353. Research Programs/Design for This Report
- Table 354. Authors List of This Report
- Table 355. Secondary Sources
- Table 356. Primary Sources
List of Figures
- Figure 1. Biological Sample Cryopreservation Image
- Figure 2. Global Biological Sample Cryopreservation Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032
- Figure 3. Global Biological Sample Cryopreservation Market Size Share 2021 VS 2025 VS 2032
- Figure 4. Cryopreservation Equipment Image
- Figure 5. Cryopreservation Media & Reagents Image
- Figure 6. Cryopreservation Containers & Accessories Image
- Figure 7. Cryopreservation Services Image
- Figure 8. Global Biological Sample Cryopreservation Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032
- Figure 9. Global Biological Sample Cryopreservation Market Size Share 2021 VS 2025 VS 2032
- Figure 10. Biobanking Image
- Figure 11. Biomedical Research Image
- Figure 12. Biopharmaceutical Manufacturing Image
- Figure 13. Cell & Gene Therapy Image
- Figure 14. Assisted Reproduction Image
- Figure 15. Clinical Diagnostics Image
- Figure 16. Animal Breeding Image
- Figure 17. Global Biological Sample Cryopreservation Market Size (US$ Million) & (2021-2032)
- Figure 18. Global Biological Sample Cryopreservation Market Size, (US$ Million), 2021 VS 2025 VS 2032
- Figure 19. Global Biological Sample Cryopreservation Market Share by Region: 2021 VS 2025 VS 2032
- Figure 20. Global Biological Sample Cryopreservation Players Revenue Share Top 10 and Top 5 in 2025
- Figure 21. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
- Figure 22. Global Biological Sample Cryopreservation Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million)
- Figure 23. Global Biological Sample Cryopreservation Revenue Market Share 2021 VS 2025 VS 2032
- Figure 24. Global Biological Sample Cryopreservation Revenue Market Share by Type (2021-2032)
- Figure 25. Global Biological Sample Cryopreservation Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million)
- Figure 26. Global Biological Sample Cryopreservation Revenue Market Share by Application (2021 VS 2025 VS 2032)
- Figure 27. Global Biological Sample Cryopreservation Revenue Market Share by Application (2021-2032)
- Figure 28. North America Biological Sample Cryopreservation Revenue YoY Growth (2021-2032) & (US$ Million)
- Figure 29. North America Biological Sample Cryopreservation Revenue Share by Type (2021-2032)
- Figure 30. North America Biological Sample Cryopreservation Revenue Share by Application (2021-2032)
- Figure 31. North America Biological Sample Cryopreservation Revenue Share by Country (2021-2032)
- Figure 32. United States Biological Sample Cryopreservation Revenue YoY Growth (US$ Million) & (2021-2032)
- Figure 33. Canada Biological Sample Cryopreservation Revenue YoY Growth (US$ Million) & (2021-2032)
- Figure 34. Mexico Biological Sample Cryopreservation Revenue YoY Growth (US$ Million) & (2021-2032)
- Figure 35. Europe Biological Sample Cryopreservation Revenue YoY Growth (2021-2032) & (US$ Million)
- Figure 36. Europe Biological Sample Cryopreservation Revenue Share by Type (2021-2032)
- Figure 37. Europe Biological Sample Cryopreservation Revenue Share by Application (2021-2032)
- Figure 38. Europe Biological Sample Cryopreservation Revenue Share by Country (2021-2032)
- Figure 39. Germany Biological Sample Cryopreservation Revenue YoY Growth (US$ Million) & (2021-2032)
- Figure 40. France Biological Sample Cryopreservation Revenue YoY Growth (US$ Million) & (2021-2032)
- Figure 41. U.K. Biological Sample Cryopreservation Revenue YoY Growth (US$ Million) & (2021-2032)
- Figure 42. Italy Biological Sample Cryopreservation Revenue YoY Growth (US$ Million) & (2021-2032)
- Figure 43. Spain Biological Sample Cryopreservation Revenue YoY Growth (US$ Million) & (2021-2032)
- Figure 44. Russia Biological Sample Cryopreservation Revenue YoY Growth (US$ Million) & (2021-2032)
- Figure 45. Netherlands Biological Sample Cryopreservation Revenue YoY Growth (US$ Million) & (2021-2032)
- Figure 46. Nordic Countries Biological Sample Cryopreservation Revenue YoY Growth (US$ Million) & (2021-2032)
- Figure 47. China Biological Sample Cryopreservation Revenue YoY Growth (2021-2032) & (US$ Million)
- Figure 48. China Biological Sample Cryopreservation Revenue Share by Type (2021-2032)
- Figure 49. China Biological Sample Cryopreservation Revenue Share by Application (2021-2032)
- Figure 50. Asia Biological Sample Cryopreservation Revenue YoY Growth (2021-2032) & (US$ Million)
- Figure 51. Asia Biological Sample Cryopreservation Revenue Share by Type (2021-2032)
- Figure 52. Asia Biological Sample Cryopreservation Revenue Share by Application (2021-2032)
- Figure 53. Asia Biological Sample Cryopreservation Revenue Share by Region (2021-2032)
- Figure 54. Japan Biological Sample Cryopreservation Revenue YoY Growth (US$ Million) & (2021-2032)
- Figure 55. South Korea Biological Sample Cryopreservation Revenue YoY Growth (US$ Million) & (2021-2032)
- Figure 56. India Biological Sample Cryopreservation Revenue YoY Growth (US$ Million) & (2021-2032)
- Figure 57. Australia Biological Sample Cryopreservation Revenue YoY Growth (US$ Million) & (2021-2032)
- Figure 58. Taiwan Biological Sample Cryopreservation Revenue YoY Growth (US$ Million) & (2021-2032)
- Figure 59. Southeast Asia Biological Sample Cryopreservation Revenue YoY Growth (US$ Million) & (2021-2032)
- Figure 60. SAMEA Biological Sample Cryopreservation Revenue YoY Growth (2021-2032) & (US$ Million)
- Figure 61. SAMEA Biological Sample Cryopreservation Revenue Share by Type (2021-2032)
- Figure 62. SAMEA Biological Sample Cryopreservation Revenue Share by Application (2021-2032)
- Figure 63. SAMEA Biological Sample Cryopreservation Revenue Share by Country (2021-2032)
- Figure 64. Brazil Biological Sample Cryopreservation Revenue YoY Growth (US$ Million) & (2021-2032)
- Figure 65. Argentina Biological Sample Cryopreservation Revenue YoY Growth (US$ Million) & (2021-2032)
- Figure 66. Chile Biological Sample Cryopreservation Revenue YoY Growth (US$ Million) & (2021-2032)
- Figure 67. Colombia Biological Sample Cryopreservation Revenue YoY Growth (US$ Million) & (2021-2032)
- Figure 68. Peru Biological Sample Cryopreservation Revenue YoY Growth (US$ Million) & (2021-2032)
- Figure 69. Saudi Arabia Biological Sample Cryopreservation Revenue YoY Growth (US$ Million) & (2021-2032)
- Figure 70. Israel Biological Sample Cryopreservation Revenue YoY Growth (US$ Million) & (2021-2032)
- Figure 71. UAE Biological Sample Cryopreservation Revenue YoY Growth (US$ Million) & (2021-2032)
- Figure 72. Turkey Biological Sample Cryopreservation Revenue YoY Growth (US$ Million) & (2021-2032)
- Figure 73. Iran Biological Sample Cryopreservation Revenue YoY Growth (US$ Million) & (2021-2032)
- Figure 74. Egypt Biological Sample Cryopreservation Revenue YoY Growth (US$ Million) & (2021-2032)
- Figure 75. Years Considered
- Figure 76. Research Process
- Figure 77. Key Executives Interviewed
Scope & coverage.
By Type
- Cryopreservation Equipment
- Cryopreservation Media & Reagents
- Cryopreservation Containers & Accessories
- Cryopreservation Services
By Application
- Biobanking
- Biomedical Research
- Biopharmaceutical Manufacturing
- Cell & Gene Therapy
- Assisted Reproduction
- Clinical Diagnostics
- Animal Breeding
Companies covered
- Thermo Fisher Scientific
- Haier Biomedical
- PHCbi
- Repligen
- Cryoport
- Azenta Life Sciences
- Cytiva
- Sartorius
- FUJIFILM Biosciences
- Lonza
- Corning
- Eppendorf
- Greiner
- SARSTEDT
- Terumo
- CooperSurgical
- Vitrolife
- Nexpring Health
- Macopharma
- Miltenyi Biotec
- STEMCELL Technologies
- Kitazato
- Zhongke Meiling Cryogenics
- AUCMA
- BIOBASE
- Genepoint Technologies
- Origincell Biological Cryo Equipment
- Basecare Medical
- Hamilton Company
- LiCONiC
- ASKION
- SPT Labtech
- B Medical Systems
- Custom Biogenic Systems
- IC Biomedical
- Cryo Bio System
- Stirling Ultracold
- Helmer Scientific
- Micronic
- OriGen Biomedical
- BINDER
- Liebherr
- Esco Lifesciences
- Cryopal
- Cryotherm
- Cryo Diffusion
- Statebourne Cryogenics
- Celltrio
- ThermoGenesis
- Jiangsu SERLNG
- SYLAB
- Consarctic
- PromoCell
- FertiPro
- CryoLogic
- Cryofab
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Biological Sample Cryopreservation Market by Type
- 1.2.1 Global Biological Sample Cryopreservation Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Cryopreservation Equipment
- 1.2.3 Cryopreservation Media & Reagents
- 1.2.4 Cryopreservation Containers & Accessories
- 1.2.5 Cryopreservation Services
- 1.3 Biological Sample Cryopreservation Market by Application
- 1.3.1 Global Biological Sample Cryopreservation Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Biobanking
- 1.3.3 Biomedical Research
- 1.3.4 Biopharmaceutical Manufacturing
- 1.3.5 Cell & Gene Therapy
- 1.3.6 Assisted Reproduction
- 1.3.7 Clinical Diagnostics
- 1.3.8 Animal Breeding
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Biological Sample Cryopreservation Market Dynamics
- 2.1 Biological Sample Cryopreservation Industry Trends
- 2.2 Biological Sample Cryopreservation Industry Drivers
- 2.3 Biological Sample Cryopreservation Industry Opportunities and Challenges
- 2.4 Biological Sample Cryopreservation Industry Restraints
3 Global Growth Perspective
- 3.1 Global Biological Sample Cryopreservation Market Perspective (2021-2032)
- 3.2 Global Biological Sample Cryopreservation Growth Trends by Region
- 3.2.1 Global Biological Sample Cryopreservation Market Size by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Biological Sample Cryopreservation Market Size by Region (2021-2026)
- 3.2.3 Global Biological Sample Cryopreservation Market Size by Region (2027-2032)
4 Competitive Landscape by Players
- 4.1 Global Biological Sample Cryopreservation Revenue by Players
- 4.1.1 Global Biological Sample Cryopreservation Revenue by Players (2021-2026)
- 4.1.2 Global Biological Sample Cryopreservation Revenue Market Share by Players (2021-2026)
- 4.1.3 Global Biological Sample Cryopreservation Players Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Biological Sample Cryopreservation Key Players Ranking, 2024 VS 2025 VS 2026
- 4.3 Global Biological Sample Cryopreservation Key Players Headquarters & Area Served
- 4.4 Global Biological Sample Cryopreservation Players, Product Type & Application
- 4.5 Global Biological Sample Cryopreservation Players Establishment Date
- 4.6 Market Competitive Analysis
- 4.6.1 Global Biological Sample Cryopreservation Market CR5 and HHI
- 4.6.2 2025 Biological Sample Cryopreservation Tier 1, Tier 2, and Tier 3
5 Biological Sample Cryopreservation Market Size by Type
- 5.1 Global Biological Sample Cryopreservation Revenue by Type (2021 VS 2025 VS 2032)
- 5.2 Global Biological Sample Cryopreservation Revenue by Type (2021-2032)
- 5.3 Global Biological Sample Cryopreservation Revenue Market Share by Type (2021-2032)
6 Biological Sample Cryopreservation Market Size by Application
- 6.1 Global Biological Sample Cryopreservation Revenue by Application (2021 VS 2025 VS 2032)
- 6.2 Global Biological Sample Cryopreservation Revenue by Application (2021-2032)
- 6.3 Global Biological Sample Cryopreservation Revenue Market Share by Application (2021-2032)
7 Company Profiles
- 7.1 Thermo Fisher Scientific
- 7.1.1 Thermo Fisher Scientific Company Information
- 7.1.2 Thermo Fisher Scientific Business Overview
- 7.1.3 Thermo Fisher Scientific Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
- 7.1.4 Thermo Fisher Scientific Biological Sample Cryopreservation Product Portfolio
- 7.1.5 Thermo Fisher Scientific Recent Developments
- 7.2 Haier Biomedical
- 7.2.1 Haier Biomedical Company Information
- 7.2.2 Haier Biomedical Business Overview
- 7.2.3 Haier Biomedical Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
- 7.2.4 Haier Biomedical Biological Sample Cryopreservation Product Portfolio
- 7.2.5 Haier Biomedical Recent Developments
- 7.3 PHCbi
- 7.3.1 PHCbi Company Information
- 7.3.2 PHCbi Business Overview
- 7.3.3 PHCbi Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
- 7.3.4 PHCbi Biological Sample Cryopreservation Product Portfolio
- 7.3.5 PHCbi Recent Developments
- 7.4 Repligen
- 7.4.1 Repligen Company Information
- 7.4.2 Repligen Business Overview
- 7.4.3 Repligen Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
- 7.4.4 Repligen Biological Sample Cryopreservation Product Portfolio
- 7.4.5 Repligen Recent Developments
- 7.5 Cryoport
- 7.5.1 Cryoport Company Information
- 7.5.2 Cryoport Business Overview
- 7.5.3 Cryoport Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
- 7.5.4 Cryoport Biological Sample Cryopreservation Product Portfolio
- 7.5.5 Cryoport Recent Developments
- 7.6 Azenta Life Sciences
- 7.6.1 Azenta Life Sciences Company Information
- 7.6.2 Azenta Life Sciences Business Overview
- 7.6.3 Azenta Life Sciences Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
- 7.6.4 Azenta Life Sciences Biological Sample Cryopreservation Product Portfolio
- 7.6.5 Azenta Life Sciences Recent Developments
- 7.7 Cytiva
- 7.7.1 Cytiva Company Information
- 7.7.2 Cytiva Business Overview
- 7.7.3 Cytiva Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
- 7.7.4 Cytiva Biological Sample Cryopreservation Product Portfolio
- 7.7.5 Cytiva Recent Developments
- 7.8 Sartorius
- 7.8.1 Sartorius Company Information
- 7.8.2 Sartorius Business Overview
- 7.8.3 Sartorius Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
- 7.8.4 Sartorius Biological Sample Cryopreservation Product Portfolio
- 7.8.5 Sartorius Recent Developments
- 7.9 FUJIFILM Biosciences
- 7.9.1 FUJIFILM Biosciences Company Information
- 7.9.2 FUJIFILM Biosciences Business Overview
- 7.9.3 FUJIFILM Biosciences Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
- 7.9.4 FUJIFILM Biosciences Biological Sample Cryopreservation Product Portfolio
- 7.9.5 FUJIFILM Biosciences Recent Developments
- 7.10 Lonza
- 7.10.1 Lonza Company Information
- 7.10.2 Lonza Business Overview
- 7.10.3 Lonza Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
- 7.10.4 Lonza Biological Sample Cryopreservation Product Portfolio
- 7.10.5 Lonza Recent Developments
- 7.11 Corning
- 7.11.1 Corning Company Information
- 7.11.2 Corning Business Overview
- 7.11.3 Corning Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
- 7.11.4 Corning Biological Sample Cryopreservation Product Portfolio
- 7.11.5 Corning Recent Developments
- 7.12 Eppendorf
- 7.12.1 Eppendorf Company Information
- 7.12.2 Eppendorf Business Overview
- 7.12.3 Eppendorf Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
- 7.12.4 Eppendorf Biological Sample Cryopreservation Product Portfolio
- 7.12.5 Eppendorf Recent Developments
- 7.13 Greiner
- 7.13.1 Greiner Company Information
- 7.13.2 Greiner Business Overview
- 7.13.3 Greiner Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
- 7.13.4 Greiner Biological Sample Cryopreservation Product Portfolio
- 7.13.5 Greiner Recent Developments
- 7.14 SARSTEDT
- 7.14.1 SARSTEDT Company Information
- 7.14.2 SARSTEDT Business Overview
- 7.14.3 SARSTEDT Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
- 7.14.4 SARSTEDT Biological Sample Cryopreservation Product Portfolio
- 7.14.5 SARSTEDT Recent Developments
- 7.15 Terumo
- 7.15.1 Terumo Company Information
- 7.15.2 Terumo Business Overview
- 7.15.3 Terumo Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
- 7.15.4 Terumo Biological Sample Cryopreservation Product Portfolio
- 7.15.5 Terumo Recent Developments
- 7.16 CooperSurgical
- 7.16.1 CooperSurgical Company Information
- 7.16.2 CooperSurgical Business Overview
- 7.16.3 CooperSurgical Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
- 7.16.4 CooperSurgical Biological Sample Cryopreservation Product Portfolio
- 7.16.5 CooperSurgical Recent Developments
- 7.17 Vitrolife
- 7.17.1 Vitrolife Company Information
- 7.17.2 Vitrolife Business Overview
- 7.17.3 Vitrolife Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
- 7.17.4 Vitrolife Biological Sample Cryopreservation Product Portfolio
- 7.17.5 Vitrolife Recent Developments
- 7.18 Nexpring Health
- 7.18.1 Nexpring Health Company Information
- 7.18.2 Nexpring Health Business Overview
- 7.18.3 Nexpring Health Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
- 7.18.4 Nexpring Health Biological Sample Cryopreservation Product Portfolio
- 7.18.5 Nexpring Health Recent Developments
- 7.19 Macopharma
- 7.19.1 Macopharma Company Information
- 7.19.2 Macopharma Business Overview
- 7.19.3 Macopharma Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
- 7.19.4 Macopharma Biological Sample Cryopreservation Product Portfolio
- 7.19.5 Macopharma Recent Developments
- 7.20 Miltenyi Biotec
- 7.20.1 Miltenyi Biotec Company Information
- 7.20.2 Miltenyi Biotec Business Overview
- 7.20.3 Miltenyi Biotec Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
- 7.20.4 Miltenyi Biotec Biological Sample Cryopreservation Product Portfolio
- 7.20.5 Miltenyi Biotec Recent Developments
- 7.21 STEMCELL Technologies
- 7.21.1 STEMCELL Technologies Company Information
- 7.21.2 STEMCELL Technologies Business Overview
- 7.21.3 STEMCELL Technologies Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
- 7.21.4 STEMCELL Technologies Biological Sample Cryopreservation Product Portfolio
- 7.21.5 STEMCELL Technologies Recent Developments
- 7.22 Kitazato
- 7.22.1 Kitazato Company Information
- 7.22.2 Kitazato Business Overview
- 7.22.3 Kitazato Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
- 7.22.4 Kitazato Biological Sample Cryopreservation Product Portfolio
- 7.22.5 Kitazato Recent Developments
- 7.23 Zhongke Meiling Cryogenics
- 7.23.1 Zhongke Meiling Cryogenics Company Information
- 7.23.2 Zhongke Meiling Cryogenics Business Overview
- 7.23.3 Zhongke Meiling Cryogenics Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
- 7.23.4 Zhongke Meiling Cryogenics Biological Sample Cryopreservation Product Portfolio
- 7.23.5 Zhongke Meiling Cryogenics Recent Developments
- 7.24 AUCMA
- 7.24.1 AUCMA Company Information
- 7.24.2 AUCMA Business Overview
- 7.24.3 AUCMA Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
- 7.24.4 AUCMA Biological Sample Cryopreservation Product Portfolio
- 7.24.5 AUCMA Recent Developments
- 7.25 BIOBASE
- 7.25.1 BIOBASE Company Information
- 7.25.2 BIOBASE Business Overview
- 7.25.3 BIOBASE Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
- 7.25.4 BIOBASE Biological Sample Cryopreservation Product Portfolio
- 7.25.5 BIOBASE Recent Developments
- 7.26 Genepoint Technologies
- 7.26.1 Genepoint Technologies Company Information
- 7.26.2 Genepoint Technologies Business Overview
- 7.26.3 Genepoint Technologies Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
- 7.26.4 Genepoint Technologies Biological Sample Cryopreservation Product Portfolio
- 7.26.5 Genepoint Technologies Recent Developments
- 7.27 Origincell Biological Cryo Equipment
- 7.27.1 Origincell Biological Cryo Equipment Company Information
- 7.27.2 Origincell Biological Cryo Equipment Business Overview
- 7.27.3 Origincell Biological Cryo Equipment Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
- 7.27.4 Origincell Biological Cryo Equipment Biological Sample Cryopreservation Product Portfolio
- 7.27.5 Origincell Biological Cryo Equipment Recent Developments
- 7.28 Basecare Medical
- 7.28.1 Basecare Medical Company Information
- 7.28.2 Basecare Medical Business Overview
- 7.28.3 Basecare Medical Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
- 7.28.4 Basecare Medical Biological Sample Cryopreservation Product Portfolio
- 7.28.5 Basecare Medical Recent Developments
- 7.29 Hamilton Company
- 7.29.1 Hamilton Company Company Information
- 7.29.2 Hamilton Company Business Overview
- 7.29.3 Hamilton Company Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
- 7.29.4 Hamilton Company Biological Sample Cryopreservation Product Portfolio
- 7.29.5 Hamilton Company Recent Developments
- 7.30 LiCONiC
- 7.30.1 LiCONiC Company Information
- 7.30.2 LiCONiC Business Overview
- 7.30.3 LiCONiC Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
- 7.30.4 LiCONiC Biological Sample Cryopreservation Product Portfolio
- 7.30.5 LiCONiC Recent Developments
- 7.31 ASKION
- 7.31.1 ASKION Company Information
- 7.31.2 ASKION Business Overview
- 7.31.3 ASKION Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
- 7.31.4 ASKION Biological Sample Cryopreservation Product Portfolio
- 7.31.5 ASKION Recent Developments
- 7.32 SPT Labtech
- 7.32.1 SPT Labtech Company Information
- 7.32.2 SPT Labtech Business Overview
- 7.32.3 SPT Labtech Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
- 7.32.4 SPT Labtech Biological Sample Cryopreservation Product Portfolio
- 7.32.5 SPT Labtech Recent Developments
- 7.33 B Medical Systems
- 7.33.1 B Medical Systems Company Information
- 7.33.2 B Medical Systems Business Overview
- 7.33.3 B Medical Systems Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
- 7.33.4 B Medical Systems Biological Sample Cryopreservation Product Portfolio
- 7.33.5 B Medical Systems Recent Developments
- 7.34 Custom Biogenic Systems
- 7.34.1 Custom Biogenic Systems Company Information
- 7.34.2 Custom Biogenic Systems Business Overview
- 7.34.3 Custom Biogenic Systems Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
- 7.34.4 Custom Biogenic Systems Biological Sample Cryopreservation Product Portfolio
- 7.34.5 Custom Biogenic Systems Recent Developments
- 7.35 IC Biomedical
- 7.35.1 IC Biomedical Company Information
- 7.35.2 IC Biomedical Business Overview
- 7.35.3 IC Biomedical Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
- 7.35.4 IC Biomedical Biological Sample Cryopreservation Product Portfolio
- 7.35.5 IC Biomedical Recent Developments
- 7.36 Cryo Bio System
- 7.36.1 Cryo Bio System Company Information
- 7.36.2 Cryo Bio System Business Overview
- 7.36.3 Cryo Bio System Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
- 7.36.4 Cryo Bio System Biological Sample Cryopreservation Product Portfolio
- 7.36.5 Cryo Bio System Recent Developments
- 7.37 Stirling Ultracold
- 7.37.1 Stirling Ultracold Company Information
- 7.37.2 Stirling Ultracold Business Overview
- 7.37.3 Stirling Ultracold Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
- 7.37.4 Stirling Ultracold Biological Sample Cryopreservation Product Portfolio
- 7.37.5 Stirling Ultracold Recent Developments
- 7.38 Helmer Scientific
- 7.38.1 Helmer Scientific Company Information
- 7.38.2 Helmer Scientific Business Overview
- 7.38.3 Helmer Scientific Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
- 7.38.4 Helmer Scientific Biological Sample Cryopreservation Product Portfolio
- 7.38.5 Helmer Scientific Recent Developments
- 7.39 Micronic
- 7.39.1 Micronic Company Information
- 7.39.2 Micronic Business Overview
- 7.39.3 Micronic Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
- 7.39.4 Micronic Biological Sample Cryopreservation Product Portfolio
- 7.39.5 Micronic Recent Developments
- 7.40 OriGen Biomedical
- 7.40.1 OriGen Biomedical Company Information
- 7.40.2 OriGen Biomedical Business Overview
- 7.40.3 OriGen Biomedical Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
- 7.40.4 OriGen Biomedical Biological Sample Cryopreservation Product Portfolio
- 7.40.5 OriGen Biomedical Recent Developments
- 7.41 BINDER
- 7.41.1 BINDER Company Information
- 7.41.2 BINDER Business Overview
- 7.41.3 BINDER Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
- 7.41.4 BINDER Biological Sample Cryopreservation Product Portfolio
- 7.41.5 BINDER Recent Developments
- 7.42 Liebherr
- 7.42.1 Liebherr Company Information
- 7.42.2 Liebherr Business Overview
- 7.42.3 Liebherr Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
- 7.42.4 Liebherr Biological Sample Cryopreservation Product Portfolio
- 7.42.5 Liebherr Recent Developments
- 7.43 Esco Lifesciences
- 7.43.1 Esco Lifesciences Company Information
- 7.43.2 Esco Lifesciences Business Overview
- 7.43.3 Esco Lifesciences Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
- 7.43.4 Esco Lifesciences Biological Sample Cryopreservation Product Portfolio
- 7.43.5 Esco Lifesciences Recent Developments
- 7.44 Cryopal
- 7.44.1 Cryopal Company Information
- 7.44.2 Cryopal Business Overview
- 7.44.3 Cryopal Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
- 7.44.4 Cryopal Biological Sample Cryopreservation Product Portfolio
- 7.44.5 Cryopal Recent Developments
- 7.45 Cryotherm
- 7.45.1 Cryotherm Company Information
- 7.45.2 Cryotherm Business Overview
- 7.45.3 Cryotherm Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
- 7.45.4 Cryotherm Biological Sample Cryopreservation Product Portfolio
- 7.45.5 Cryotherm Recent Developments
- 7.46 Cryo Diffusion
- 7.46.1 Cryo Diffusion Company Information
- 7.46.2 Cryo Diffusion Business Overview
- 7.46.3 Cryo Diffusion Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
- 7.46.4 Cryo Diffusion Biological Sample Cryopreservation Product Portfolio
- 7.46.5 Cryo Diffusion Recent Developments
- 7.47 Statebourne Cryogenics
- 7.47.1 Statebourne Cryogenics Company Information
- 7.47.2 Statebourne Cryogenics Business Overview
- 7.47.3 Statebourne Cryogenics Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
- 7.47.4 Statebourne Cryogenics Biological Sample Cryopreservation Product Portfolio
- 7.47.5 Statebourne Cryogenics Recent Developments
- 7.48 Celltrio
- 7.48.1 Celltrio Company Information
- 7.48.2 Celltrio Business Overview
- 7.48.3 Celltrio Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
- 7.48.4 Celltrio Biological Sample Cryopreservation Product Portfolio
- 7.48.5 Celltrio Recent Developments
- 7.49 ThermoGenesis
- 7.49.1 ThermoGenesis Company Information
- 7.49.2 ThermoGenesis Business Overview
- 7.49.3 ThermoGenesis Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
- 7.49.4 ThermoGenesis Biological Sample Cryopreservation Product Portfolio
- 7.49.5 ThermoGenesis Recent Developments
- 7.50 Jiangsu SERLNG
- 7.50.1 Jiangsu SERLNG Company Information
- 7.50.2 Jiangsu SERLNG Business Overview
- 7.50.3 Jiangsu SERLNG Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
- 7.50.4 Jiangsu SERLNG Biological Sample Cryopreservation Product Portfolio
- 7.50.5 Jiangsu SERLNG Recent Developments
- 7.51 SYLAB
- 7.51.1 SYLAB Company Information
- 7.51.2 SYLAB Business Overview
- 7.51.3 SYLAB Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
- 7.51.4 SYLAB Biological Sample Cryopreservation Product Portfolio
- 7.51.5 SYLAB Recent Developments
- 7.52 Consarctic
- 7.52.1 Consarctic Company Information
- 7.52.2 Consarctic Business Overview
- 7.52.3 Consarctic Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
- 7.52.4 Consarctic Biological Sample Cryopreservation Product Portfolio
- 7.52.5 Consarctic Recent Developments
- 7.53 PromoCell
- 7.53.1 PromoCell Company Information
- 7.53.2 PromoCell Business Overview
- 7.53.3 PromoCell Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
- 7.53.4 PromoCell Biological Sample Cryopreservation Product Portfolio
- 7.53.5 PromoCell Recent Developments
- 7.54 FertiPro
- 7.54.1 FertiPro Company Information
- 7.54.2 FertiPro Business Overview
- 7.54.3 FertiPro Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
- 7.54.4 FertiPro Biological Sample Cryopreservation Product Portfolio
- 7.54.5 FertiPro Recent Developments
- 7.55 CryoLogic
- 7.55.1 CryoLogic Company Information
- 7.55.2 CryoLogic Business Overview
- 7.55.3 CryoLogic Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
- 7.55.4 CryoLogic Biological Sample Cryopreservation Product Portfolio
- 7.55.5 CryoLogic Recent Developments
- 7.56 Cryofab
- 7.56.1 Cryofab Company Information
- 7.56.2 Cryofab Business Overview
- 7.56.3 Cryofab Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
- 7.56.4 Cryofab Biological Sample Cryopreservation Product Portfolio
- 7.56.5 Cryofab Recent Developments
8 North America
- 8.1 North America Biological Sample Cryopreservation Revenue (2021-2032)
- 8.2 North America Biological Sample Cryopreservation Revenue by Type (2021-2032)
- 8.2.1 North America Biological Sample Cryopreservation Revenue by Type (2021-2026)
- 8.2.2 North America Biological Sample Cryopreservation Revenue by Type (2027-2032)
- 8.3 North America Biological Sample Cryopreservation Revenue Share by Type (2021-2032)
- 8.4 North America Biological Sample Cryopreservation Revenue by Application (2021-2032)
- 8.4.1 North America Biological Sample Cryopreservation Revenue by Application (2021-2026)
- 8.4.2 North America Biological Sample Cryopreservation Revenue by Application (2027-2032)
- 8.5 North America Biological Sample Cryopreservation Revenue Share by Application (2021-2032)
- 8.6 North America Biological Sample Cryopreservation Revenue by Country
- 8.6.1 North America Biological Sample Cryopreservation Revenue by Country (2021 VS 2025 VS 2032)
- 8.6.2 North America Biological Sample Cryopreservation Revenue by Country (2021-2026)
- 8.6.3 North America Biological Sample Cryopreservation Revenue by Country (2027-2032)
- 8.6.4 United States
- 8.6.5 Canada
- 8.6.6 Mexico
9 Europe
- 9.1 Europe Biological Sample Cryopreservation Revenue (2021-2032)
- 9.2 Europe Biological Sample Cryopreservation Revenue by Type (2021-2032)
- 9.2.1 Europe Biological Sample Cryopreservation Revenue by Type (2021-2026)
- 9.2.2 Europe Biological Sample Cryopreservation Revenue by Type (2027-2032)
- 9.3 Europe Biological Sample Cryopreservation Revenue Share by Type (2021-2032)
- 9.4 Europe Biological Sample Cryopreservation Revenue by Application (2021-2032)
- 9.4.1 Europe Biological Sample Cryopreservation Revenue by Application (2021-2026)
- 9.4.2 Europe Biological Sample Cryopreservation Revenue by Application (2027-2032)
- 9.5 Europe Biological Sample Cryopreservation Revenue Share by Application (2021-2032)
- 9.6 Europe Biological Sample Cryopreservation Revenue by Country
- 9.6.1 Europe Biological Sample Cryopreservation Revenue by Country (2021 VS 2025 VS 2032)
- 9.6.2 Europe Biological Sample Cryopreservation Revenue by Country (2021-2026)
- 9.6.3 Europe Biological Sample Cryopreservation Revenue by Country (2027-2032)
- 9.6.4 Germany
- 9.6.5 France
- 9.6.6 U.K.
- 9.6.7 Italy
- 9.6.8 Russia
- 9.6.9 Spain
- 9.6.10 Netherlands
- 9.6.11 Switzerland
- 9.6.12 Sweden
- 9.6.13 Poland
10 China
- 10.1 China Biological Sample Cryopreservation Revenue (2021-2032)
- 10.2 China Biological Sample Cryopreservation Revenue by Type (2021-2032)
- 10.2.1 China Biological Sample Cryopreservation Revenue by Type (2021-2026)
- 10.2.2 China Biological Sample Cryopreservation Revenue by Type (2027-2032)
- 10.3 China Biological Sample Cryopreservation Revenue Share by Type (2021-2032)
- 10.4 China Biological Sample Cryopreservation Revenue by Application (2021-2032)
- 10.4.1 China Biological Sample Cryopreservation Revenue by Application (2021-2026)
- 10.4.2 China Biological Sample Cryopreservation Revenue by Application (2027-2032)
- 10.5 China Biological Sample Cryopreservation Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Biological Sample Cryopreservation Revenue (2021-2032)
- 11.2 Asia Biological Sample Cryopreservation Revenue by Type (2021-2032)
- 11.2.1 Asia Biological Sample Cryopreservation Revenue by Type (2021-2026)
- 11.2.2 Asia Biological Sample Cryopreservation Revenue by Type (2027-2032)
- 11.3 Asia Biological Sample Cryopreservation Revenue Share by Type (2021-2032)
- 11.4 Asia Biological Sample Cryopreservation Revenue by Application (2021-2032)
- 11.4.1 Asia Biological Sample Cryopreservation Revenue by Application (2021-2026)
- 11.4.2 Asia Biological Sample Cryopreservation Revenue by Application (2027-2032)
- 11.5 Asia Biological Sample Cryopreservation Revenue Share by Application (2021-2032)
- 11.6 Asia Biological Sample Cryopreservation Revenue by Country
- 11.6.1 Asia Biological Sample Cryopreservation Revenue by Country (2021 VS 2025 VS 2032)
- 11.6.2 Asia Biological Sample Cryopreservation Revenue by Country (2021-2026)
- 11.6.3 Asia Biological Sample Cryopreservation Revenue by Country (2027-2032)
- 11.6.4 Japan
- 11.6.5 South Korea
- 11.6.6 India
- 11.6.7 Australia
- 11.6.8 Taiwan
- 11.6.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Biological Sample Cryopreservation Revenue (2021-2032)
- 12.2 SAMEA Biological Sample Cryopreservation Revenue by Type (2021-2032)
- 12.2.1 SAMEA Biological Sample Cryopreservation Revenue by Type (2021-2026)
- 12.2.2 SAMEA Biological Sample Cryopreservation Revenue by Type (2027-2032)
- 12.3 SAMEA Biological Sample Cryopreservation Revenue Share by Type (2021-2032)
- 12.4 SAMEA Biological Sample Cryopreservation Revenue by Application (2021-2032)
- 12.4.1 SAMEA Biological Sample Cryopreservation Revenue by Application (2021-2026)
- 12.4.2 SAMEA Biological Sample Cryopreservation Revenue by Application (2027-2032)
- 12.5 SAMEA Biological Sample Cryopreservation Revenue Share by Application (2021-2032)
- 12.6 SAMEA Biological Sample Cryopreservation Revenue by Country
- 12.6.1 SAMEA Biological Sample Cryopreservation Revenue by Country (2021 VS 2025 VS 2032)
- 12.6.2 SAMEA Biological Sample Cryopreservation Revenue by Country (2021-2026)
- 12.6.3 SAMEA Biological Sample Cryopreservation Revenue by Country (2027-2032)
- 12.6.4 Brazil
- 12.6.5 Argentina
- 12.6.6 Chile
- 12.6.7 Colombia
- 12.6.8 Peru
- 12.6.9 Saudi Arabia
- 12.6.10 Israel
- 12.6.11 UAE
- 12.6.12 Turkey
- 12.6.13 Iran
- 12.6.14 Egypt
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst